- Home
- MSM vs ACLX Comparison
MSM vs ACLX Comparison
Compare MSM & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSM
- ACLX
- Stock Information
- Founded
- MSM 1941
- ACLX 2015
- Country
- MSM United States
- ACLX United States
- Employees
- MSM N/A
- ACLX N/A
- Industry
- MSM Industrial Machinery/Components
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- MSM Industrials
- ACLX Health Care
- Exchange
- MSM Nasdaq
- ACLX Nasdaq
- Market Cap
- MSM 4.6B
- ACLX 3.5B
- IPO Year
- MSM 1995
- ACLX 2022
- Fundamental
- Price
- MSM $85.00
- ACLX $65.33
- Analyst Decision
- MSM Hold
- ACLX Strong Buy
- Analyst Count
- MSM 5
- ACLX 14
- Target Price
- MSM $85.40
- ACLX $111.42
- AVG Volume (30 Days)
- MSM 480.7K
- ACLX 566.7K
- Earning Date
- MSM 07-01-2025
- ACLX 08-07-2025
- Dividend Yield
- MSM 3.98%
- ACLX N/A
- EPS Growth
- MSM N/A
- ACLX N/A
- EPS
- MSM 3.80
- ACLX N/A
- Revenue
- MSM $3,751,835,000.00
- ACLX $76,809,000.00
- Revenue This Year
- MSM N/A
- ACLX N/A
- Revenue Next Year
- MSM $3.66
- ACLX $112.68
- P/E Ratio
- MSM $22.45
- ACLX N/A
- Revenue Growth
- MSM N/A
- ACLX N/A
- 52 Week Low
- MSM $68.10
- ACLX $47.86
- 52 Week High
- MSM $90.81
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- MSM 63.95
- ACLX 53.26
- Support Level
- MSM $80.08
- ACLX $62.70
- Resistance Level
- MSM $82.45
- ACLX $65.33
- Average True Range (ATR)
- MSM 1.54
- ACLX 2.57
- MACD
- MSM 0.07
- ACLX -0.24
- Stochastic Oscillator
- MSM 98.85
- ACLX 47.19
About MSM MSC Industrial Direct Company Inc.
Founded in 1941, MSC Industrial Direct originally manufactured and sold cutting tools to metalworking shops in New York. Through a series of acquisitions and organic expansions, MSC has grown into an industrial distribution powerhouse with a focus on specialized metalworking products and services. The firm also distributes a wide breadth of maintenance, repair, and operations (MRO) supplies. MSC primarily operates within North America where it derives over 95% of its revenue.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.